By Matthew Bultman ( August 14, 2015, 1:58 PM EDT) -- Boehringer Ingelheim Pharmaceuticals Inc. and other drugmakers continued their push to dismiss six retailers' pay-for-delay lawsuits over the stroke drug Aggrenox, arguing a recent ruling in a similar case does nothing to bolster the retailers' case....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.